Aryl hydrocarbon receptor suppresses the osteogenesis of mesenchymal stem cells in collagen-induced arthritic mice through the inhibition of β-catenin

Experimental Cell Research

Volumn 350, Issue 2, 2017, Pages 349-357

  Tong, Yulong ^a   Niu, Menglin ^a,b   Du, Yuxuan ^a   Mei, Wentong ^a   Cao, Wei ^a   Dou, Yunpeng ^a   Yu, Haitao ^c   Du, Xiaonan ^a   Yuan, Huihui ^a   Zhao, Wenming ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c LANZHOU UNIVERSITY   (China)

Author keywords

Aryl hydrocarbon receptor (Ahr); Collagen induced arthritis (CIA); Differentiation; Mesenchymal stem cell (MSC); Osteogenesis; catenin

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALKALINE PHOSPHATASE; AROMATIC HYDROCARBON RECEPTOR; BETA CATENIN; MESSENGER RNA; TRANSCRIPTION FACTOR RUNX2; WNT3A PROTEIN; POLYCHLORINATED DIBENZODIOXIN; RUNX2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE DEVELOPMENT; BONE EROSION; BONE REMODELING; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; WNT SIGNALING PATHWAY; ANIMAL; CELL CULTURE; DBA MOUSE; DRUG EFFECTS; EXPERIMENTAL ARTHRITIS; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

ALKALINE PHOSPHATASE; ANIMALS; ARTHRITIS, EXPERIMENTAL; BETA CATENIN; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED DBA; OSTEOBLASTS; OSTEOGENESIS; POLYCHLORINATED DIBENZODIOXINS; RECEPTORS, ARYL HYDROCARBON; WNT SIGNALING PATHWAY;

EID: 85008414359     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2016.12.009     Document Type: Article

References (44)

1. [1] Walsh, N.C., Gravallese, E.M., Bone remodeling in rheumatic disease: a question of balance. Immunol. Rev. 233 (2010), 301–312.
2. [2] Scott, D.L., Wolfe, F., Huizinga, T.W., Rheumatoid arthritis. Lancet 376 (2010), 1094–1108.
3. [3] Firestein, G.S., Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J. Clin. Rheuma. 11 (2005), S39–S44.
4. [4] Klareskog, L., Catrina, A.I., Paget, S., Rheumatoid arthritis. Lancet 373 (2009), 659–672.
5. [5] Schett, G., Gravallese, E., Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat. Rev. Rheuma. 8 (2012), 656–664.
6. [6] Shaw, A.T., Gravallese, E.M., Mediators of inflammation and bone remodeling in rheumatic disease. Semin Cell Dev. Biol. 49 (2016), 2–10.
7. [7] Braun, T., Zwerina, J., Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Res. Ther., 13, 2011, 235.
8. [8] Baum, R., Gravallese, E.M., Impact of inflammation on the osteoblast in rheumatic diseases. Curr. Osteoporos. Rep. 12 (2014), 9–16.
9. [9] Walsh, N.C., Reinwald, S., Manning, C.A., Condon, K.W., Iwata, K., Burr, D.B., Gravallese, E.M., Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J. Bone Min. Res. 24 (2009), 1572–1585.
10. [10] Li, B., Shao, Q., Ji, D., Li, F., Chen, G., Mesenchymal stem cells mitigate cirrhosis through BMP7. Cell Physiol. Biochem. 35 (2015), 433–440.
11. [11] Fu, X., Yang, H., Zhang, H., Wang, G., Liu, K., Gu, Q., Tao, Y., Chen, G., Jiang, X., Li, G., Gu, Y., Shi, Q., Improved osteogenesis and upregulated immunogenicity in human placenta-derived mesenchymal stem cells primed with osteogenic induction medium. Stem Cell Res. Ther., 7, 2016, 138.
12. [12] Wang, C., Meng, H., Wang, X., Zhao, C., Peng, J., Wang, Y., Differentiation of bone marrow mesenchymal stem cells in osteoblasts and adipocytes and its role in treatment of osteoporosis. Med Sci. Monit. 22 (2016), 226–233.
13. [13] Esser, C., Rannug, A., The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharm. Rev. 67 (2015), 259–279.
14. [14] Frauenstein, K., Tigges, J., Soshilov, A.A., Kado, S., Raab, N., Fritsche, E., Haendeler, J., Denison, M.S., Vogel, C.F., Haarmann-Stemmann, T., Activation of the aryl hydrocarbon receptor by the widely used Src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl) pyrazolo[3,4-d]pyrimidine (PP2). Arch. Toxicol. 89 (2015), 1329–1336.
15. [15] Kobayashi, S., Okamoto, H., Iwamoto, T., Toyama, Y., Tomatsu, T., Yamanaka, H., Momohara, S., A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. Rheumatology 47 (2008), 1317–1322.
16. [16] Nakahama, T., Kimura, A., Nguyen, N.T., Chinen, I., Hanieh, H., Nohara, K., Fujii-Kuriyama, Y., Kishimoto, T., Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 108 (2011), 14222–14227.
17. [17] Korkalainen, M., Kallio, E., Olkku, A., Nelo, K., Ilvesaro, J., Tuukkanen, J., Mahonen, A., Viluksela, M., Dioxins interfere with differentiation of osteoblasts and osteoclasts. Bone 44 (2009), 1134–1142.
18. [18] Yu, H., Du, Y., Zhang, X., Sun, Y., Li, S., Dou, Y., Li, Z., Yuan, H., Zhao, W., The aryl hydrocarbon receptor suppresses osteoblast proliferation and differentiation through the activation of the ERK signaling pathway. Toxicol. Appl Pharm. 280 (2014), 502–510.
19. [19] Monroe, D.G., McGee-Lawrence, M.E., Oursler, M.J., Westendorf, J.J., Update on Wnt signaling in bone cell biology and bone disease. Gene 492 (2012), 1–18.
20. [20] Kobayashi, Y., Uehara, S., Udagawa, N., Takahashi, N., Regulation of bone metabolism by Wnt signals. J. Biochem. 159 (2016), 387–392.
21. [21] Prochazkova, J., Kabatkova, M., Bryja, V., Umannova, L., Bernatik, O., Kozubik, A., Machala, M., Vondracek, J., The interplay of the aryl hydrocarbon receptor and beta-catenin alters both AhR-dependent transcription and Wnt/beta-catenin signaling in liver progenitors. Toxicol. Sci. 122 (2011), 349–360.
22. [22] Mathew, L.K., Sengupta, S.S., Ladu, J., Andreasen, E.A., Tanguay, R.L., Crosstalk between AHR and Wnt signaling through R-Spondin1 impairs tissue regeneration in zebrafish. Faseb J. 22 (2008), 3087–3096.
23. [23] Hruba, E., Vondracek, J., Libalova, H., Topinka, J., Bryja, V., Soucek, K., Machala, M., Gene expression changes in human prostate carcinoma cells exposed to genotoxic and nongenotoxic aryl hydrocarbon receptor ligands. Toxicol. Lett. 206 (2011), 178–188.
24. [24] Chesire, D.R., Dunn, T.A., Ewing, C.M., Luo, J., Isaacs, W.B., Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cells. Cancer Res. 64 (2004), 2523–2533.
25. [25] Brand, D.D., Latham, K.A., Rosloniec, E.F., Collagen-induced arthritis. Nat. Protoc. 2 (2007), 1269–1275.
26. [26] Yuan, H., Qian, H., Liu, S., Zhang, X., Li, S., Wang, W., Li, Z., Jia, J., Zhao, W., Therapeutic role of a vaccine targeting RANKL and TNF-alpha on collagen-induced arthritis. Biomaterials 33 (2012), 8177–8185.
27. [27] Kim, S.E., Yoon, J.Y., Jeong, W.J., Jeon, S.H., Park, Y., Yoon, J.B., Park, Y.N., Kim, H., Choi, K.Y., H-Ras is degraded by Wnt/beta-catenin signaling via beta-TrCP-mediated polyubiquitylation. J. Cell Sci. 122 (2009), 842–848.
28. [28] Kimura, A., Naka, T., Nohara, K., Fujii-Kuriyama, Y., Kishimoto, T., Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc. Natl. Acad. Sci. USA 105 (2008), 9721–9726.
29. [29] Stobbe-Maicherski, N., Wolff, S., Wolff, C., Abel, J., Sydlik, U., Frauenstein, K., Haarmann-Stemmann, T., The interleukin-6-type cytokine oncostatin M induces aryl hydrocarbon receptor expression in a STAT3-dependent manner in human HepG2 hepatoma cells. Febs J. 280 (2013), 6681–6690.
30. [30] Vimalraj, S., Arumugam, B., Miranda, P.J., Selvamurugan, N., Runx2: structure, function, and phosphorylation in osteoblast differentiation. Int. J. Biol. Macromol. 78 (2015), 202–208.
31. [31] Stopp, S., Bornhauser, M., Ugarte, F., Wobus, M., Kuhn, M., Brenner, S., Thieme, S., Expression of the melanoma cell adhesion molecule in human mesenchymal stromal cells regulates proliferation, differentiation, and maintenance of hematopoietic stem and progenitor cells. Haematologica 98 (2013), 505–513.
32. [32] Salamon, A., Adam, S., Rychly, J., Peters, K., Long-term tumor necrosis factor treatment induces NFkappaB activation and proliferation, but not osteoblastic differentiation of adipose tissue-derived mesenchymal stem cells in vitro. Int. J. Biochem. Cell Biol. 54 (2014), 149–162.
33. [33] Mao, A.S., Shin, J.W., Mooney, D.J., Effects of substrate stiffness and cell-cell contact on mesenchymal stem cell differentiation. Biomarerials 98 (2016), 184–191.
34. [34] Naruse, M., Ishihara, Y., Miyagawa-Tomita, S., Koyama, A., Hagiwara, H., 3-Methylcholanthrene, which binds to the arylhydrocarbon receptor, inhibits proliferation and differentiation of osteoblasts in vitro and ossification in vivo. Endocrinology 143 (2002), 3575–3581.
35. [35] Herlin, M., Oberg, M., Ringblom, J., Joseph, B., Korkalainen, M., Viluksela, M., Heimeier, R.A., Hakansson, H., Inhibitory effects on osteoblast differentiation in vitro by the polychlorinated biphenyl mixture Aroclor 1254 are mainly associated with the dioxin-like constituents. Toxicol. Vitr. 29 (2015), 876–883.
36. [36] Wang, T., Wang, Y., Menendez, A., Fong, C., Babey, M., Tahimic, C.G., Cheng, Z., Li, A., Chang, W., Bikle, D.D., Osteoblast-Specific Loss of IGF1R Signaling Results in Impaired Endochondral Bone Formation During Fracture Healing. J. Bone Min. Res. 30 (2015), 1572–1584.
37. [37] Harvey, W.A., Jurgensen, K., Pu, X., Lamb, C.L., Cornell, K.A., Clark, R.J., Klocke, C., Mitchell, K.A., Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increases human hepatic stellate cell activation. Toxicology 344–346 (2016), 26–33.
38. [38] Gao, Z., Bu, Y., Zhang, G., Liu, X., Wang, X., Ding, S., Wang, E., Shi, R., Li, Q., Fu, J., Yu, Z., Effect of TCDD on the fate of epithelial cells isolated from human fetal palatal shelves (hFPECs). Toxicol. Appl. Pharm. 305 (2016), 186–193.
39. [39] Li, Y., Wang, K., Zou, Q.Y., Magness, R.R., Zheng, J., 2,3,7,8-Tetrachlorodibenzo-p-dioxin differentially suppresses angiogenic responses in human placental vein and artery endothelial cells. Toxicology 336 (2015), 70–78.
40. [40] Yoshioka, H., Hiromori, Y., Aoki, A., Kimura, T., Fujii-Kuriyama, Y., Nagase, H., Nakanishi, T., Possible aryl hydrocarbon receptor-independent pathway of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced antiproliferative response in human breast cancer cells. Toxicol. Lett. 211 (2012), 257–265.
41. [41] Zhang, R., Oyajobi, B.O., Harris, S.E., Chen, D., Tsao, C., Deng, H., Zhao, M., Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 52 (2013), 145–156.
42. [42] Xu, G., Zhou, Q., Wan, C., Wang, Y., Liu, J., Li, Y., Nie, X., Cheng, C., Chen, G., 2,3,7,8-TCDD induces neurotoxicity and neuronal apoptosis in the rat brain cortex and PC12 cell line through the down-regulation of the Wnt/beta-catenin signaling pathway. Neurotoxicology 37 (2013), 63–73.
43. [43] Faust, D., Vondracek, J., Krcmar, P., Smerdova, L., Prochazkova, J., Hruba, E., Hulinkova, P., Kaina, B., Dietrich, C., Machala, M., AhR-mediated changes in global gene expression in rat liver progenitor cells. Arch. Toxicol. 87 (2013), 681–698.
44. [44] Kawajiri, K., Kobayashi, Y., Ohtake, F., Ikuta, T., Matsushima, Y., Mimura, J., Pettersson, S., Pollenz, R.S., Sakaki, T., Hirokawa, T., Akiyama, T., Kurosumi, M., Poellinger, L., Kato, S., Fujii-Kuriyama, Y., Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands. Proc. Natl. Acad. Sci. USA 106 (2009), 13481–13486.